Nuveen’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.3M | Sell |
592,124
-107,767
| -15% | -$7.6M | 0.01% | 775 |
|
|
2025
Q4 | $47.1M | Buy |
699,891
+46,770
| +7% | +$3.15M | 0.01% | 676 |
|
|
2025
Q3 | $47.9M | Buy |
653,121
+172,721
| +36% | +$11.5M | 0.01% | 631 |
|
|
2025
Q2 | $25M | Sell |
480,400
-948,397
| -66% | -$54M | 0.01% | 957 |
|
|
2025
Q1 | $91.2M | Sell |
1,428,797
-101,722
| -7% | -$5.91M | 0.03% | 422 |
|
|
2024
Q4 | $73.2M | Sell |
1,530,519
-8,634
| -0.6% | -$443K | 0.02% | 496 |
|
|
2024
Q3 | $88.1M | Sell |
1,539,153
-62,445
| -4% | -$3.58M | 0.02% | 454 |
|
|
2024
Q2 | $83.9M | Sell |
1,601,598
-50,012
| -3% | -$2.19M | 0.02% | 456 |
|
|
2024
Q1 | $67.2M | Buy |
1,651,610
+126,408
| +8% | +$4.74M | 0.02% | 540 |
|
|
2023
Q4 | $56.4M | Sell |
1,525,202
-19,644
| -1% | -$740K | 0.02% | 560 |
|
|
2023
Q3 | $59M | Buy |
1,544,846
+182,141
| +13% | +$7.46M | 0.02% | 511 |
|
|
2023
Q2 | $49.2M | Buy |
1,362,705
+128,147
| +10% | +$4.37M | 0.02% | 579 |
|
|
2023
Q1 | $47.1M | Buy |
1,234,558
+239,022
| +24% | +$11.2M | 0.02% | 572 |
|
|
2022
Q4 | $56.6M | Sell |
995,536
-39,987
| -4% | -$2.05M | 0.02% | 501 |
|
|
2022
Q3 | $40.9M | Buy |
1,035,523
+20,727
| +2% | +$916K | 0.02% | 608 |
|
|
2022
Q2 | $44.6M | Buy |
1,014,796
+53,462
| +6% | +$2.31M | 0.02% | 602 |
|
|
2022
Q1 | $35.8M | Sell |
961,334
-8,984
| -0.9% | -$320K | 0.01% | 813 |
|
|
2021
Q4 | $39M | Sell |
970,318
-41,490
| -4% | -$1.55M | 0.01% | 818 |
|
|
2021
Q3 | $41.2M | Buy |
1,011,808
+93,456
| +10% | +$3.91M | 0.01% | 791 |
|
|
2021
Q2 | $41.7M | Buy |
918,352
+26,846
| +3% | +$1.19M | 0.01% | 843 |
|
|
2021
Q1 | $37.2M | Sell |
891,506
-124,205
| -12% | -$5.67M | 0.01% | 895 |
|
|
2020
Q4 | $43.4M | Sell |
1,015,711
-23,909
| -2% | -$859K | 0.01% | 769 |
|
|
2020
Q3 | $27.3M | Buy |
1,039,620
+12,043
| +1% | +$335K | 0.01% | 879 |
|
|
2020
Q2 | $27.5M | Sell |
1,027,577
-65,325
| -6% | -$1.47M | 0.01% | 845 |
|
|
2020
Q1 | $19.7M | Sell |
1,092,902
-334,423
| -23% | -$6.35M | 0.01% | 914 |
|
|
2019
Q4 | $25.3M | Buy |
1,427,325
+161,984
| +13% | +$2.81M | 0.01% | 1036 |
|
|
2019
Q3 | $19.6M | Sell |
1,265,341
-220,740
| -15% | -$3.64M | 0.01% | 1142 |
|
|
2019
Q2 | $25.5M | Buy |
+1,486,081
| New | +$24M | 0.01% | 1027 |
|
|
2018
Q3 | – | Sell |
-22,883
| Closed | -$386K | – | 1050 |
|
|
2018
Q2 | $386K | Sell |
22,883
-963
| -4% | -$18.2K | ﹤0.01% | 913 |
|
|
2018
Q1 | $467K | Hold |
23,846
| – | – | ﹤0.01% | 903 |
|
|
2017
Q4 | $483K | Buy |
+23,846
| New | +$438K | ﹤0.01% | 903 |
|
Other funds holding HALO
VCM
VPM
Nuveen's HALO Position: Q1 2026 in Review
Nuveen reduced its Halozyme (HALO) stake by 15% in Q1 2026, selling an estimated $7.6M and leaving 592,124 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #775.
Nuveen first reported a position in HALO in Q4 2017 and has held it in 31 quarters since. The position peaked at $91.2M in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Nuveen held 592,124 shares of Halozyme worth $38.3M as of Q1 2026.
- Nuveen sold 107,767 Halozyme shares in Q1 2026, an estimated $7.6M.
- Halozyme made up 0.01% of Nuveen's portfolio in Q1 2026, its #775 holding.
- Nuveen first reported a position in Halozyme in Q4 2017 and has held it in 31 quarters since.
- Nuveen's Halozyme position peaked at $91.2M in Q1 2025.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.